Related Experiment Videos

[Life-threatening gastrointestinal toxicity during 5-fluorouracil therapy]

S Biran, D krasnokuki, G Brufman

|August 1, 1977

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter study.

American journal of clinical oncology·2001

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma.

Cancer·2000

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998

Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer. The Epirubicin High Dose (HEPI 010) Study Group.

Annals of oncology : official journal of the European Society for Medical Oncology·1997

Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literature.

European journal of gynaecological oncology·1997

See all related articles